In optogenetic therapy for retinal degeneration, in the rd1 mouse model, delivery of ChR2 with electroporation to the ON bipolar cells induced light-evoked activity in the ganglion cells and cortex (Lagali et al., 2008). This evidence concerns the gene PDE6B and retinal degeneration.